Ginkgo Biosecurity and the Rwanda Biomedical Centre (RBC) today announced a one-year pathogen monitoring program at Rwanda’s Kigali International Airport (KGL) to identify new and emerging variants of SARS-CoV-2.
Through this program, Ginkgo will collaborate with RBC to monitor wastewater samples from arriving aircraft and nasal swab samples, collected on a voluntary, anonymous basis from arriving international travelers, for SARS-CoV-2. The program aims to provide critical public health insights to help inform mitigation strategies in Rwanda and globally.
Ginkgo and RBC will work together to establish KGL as a new node in a global network of pathogen monitoring infrastructure, complementing the insights generated from Ginkgo’s existing travel biosecurity programs at several major international airports in the U.S.
Read more.
